Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High numbers of rural patients cross state lines for cancer care

2.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

3.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

4.

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

5.

Treating Depression: Crucial for Recovery From Fibromyalgia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot